1.53% 0.0387

Lumos Pharma Inc (LUMO)

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Lumos Pharma Inc Stock (LUMO) Company Profile

Lumos Pharma Inc

512-215-2630

4200 MARATHON BLVD., AUSTIN, TX

Nächster Verdiensttermin

Neueste SEC-Einreichungen

LUMO's Discussions on Twitter

Lumos Pharma Inc Stock (LUMO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-03-11	Hochstufung	Stifel	Hold → Buy
2020-12-03	Eingeleitet	Cantor Fitzgerald	Buy
2020-08-26	Eingeleitet	Piper Sandler	Overweight
2020-08-17	Fortgesetzt	ROTH Capital	Buy
2020-08-04	Eingeleitet	H.C. Wainwright	Buy

Lumos Pharma Inc Aktie (LUMO) Neueste Nachrichten

Finanzdaten der Lumos Pharma Inc-Aktie (LUMO)

Lumos Pharma Inc-Aktie (LUMO) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
McKew John C.	Chief Scientific Officer	Apr 03 '24	Sale	2.77	2,214	6,144	17,153
McKew John C.	Chief Scientific Officer	Feb 06 '24	Sale	3.03	438	1,328	18,403

Lumos Pharma Inc (LUMO)

Lumos Pharma Inc Stock (LUMO) Company Profile

Lumos Pharma Inc Stock (LUMO) Upgrades & Downgrades

Lumos Pharma Inc Aktie (LUMO) Neueste Nachrichten

AEON Biopharma (AMEX:AEON) Stock Quotes, Forecast and News Summary - Benzinga

Selling Buzz: Lumos Pharma Inc [LUMO] Chief Scientific Officer McKew John C. sells 3,407 shares of the company - Knox Daily

Taking a look at what insiders are doing to gauge the Aadi Bioscience Inc (AADI)’s direction - Knox Daily

Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024 - StockTitan

Atlantic Union Bankshares Corp [AUB] Records 50-Day SMA of $37.13 - Knox Daily

The growth track for Lumos Pharma Inc (LUMO) has changed recently - SETE News

Lumos Pharma Inc (LUMO) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

A preview of the September Tech issue of Contemporary Pediatrics - Contemporary Pediatrics

Lumos Diagnostics Holdings Full Year 2024 Earnings: US$0.018 loss per share (vs US$0.038 loss in FY 2023) - Yahoo Finance

A company insider recently sold 3,407 shares of Lumos Pharma Inc [LUMO]. Should You also Consider to Sale? - Knox Daily

Lumos Adds Prominent Security Industry Veterans to Board, Leadership Team - Yahoo Finance

Lumos Pharma to Participate in World Orphan Drug Congress USA - GuruFocus.com

Uncovering the Potential of Lumos Pharma Inc (LUMO) Stock - The InvestChronicle

Reviewing Lumos Pharma (NASDAQ:LUMO) & Korro Bio (NASDAQ:KRRO) - Defense World

Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Brokers Issue Forecasts for Lumos Pharma, Inc.’s FY2024 Earnings (NASDAQ:LUMO) - Defense World

FY2024 EPS Estimates for SIGA Technologies, Inc. Cut by Analyst (NASDAQ:SIGA) - Defense World

MAG Silver Corp. (NYSEAMERICAN:MAG) to Post FY2024 Earnings of $0.79 Per Share, Stifel Canada Forecasts - Defense World

LGI Homes, Inc. (NASDAQ:LGIH) Forecasted to Earn FY2024 Earnings of $9.10 Per Share - Defense World

Lumos Pharma (NASDAQ:LUMO) PT Lowered to $13.00 at Oppenheimer - Defense World

Lumos Pharma Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Lumos Pharma, Inc. (NASDAQ:LUMO) Q2 2024 Earnings Call Transcript - Insider Monkey

Lumos: Q2 Earnings Snapshot - The Washington Post

Lumos: Q2 Earnings Snapshot - San Francisco Chronicle

Lumos Pharma, Inc. (LUMO) Q2 2024 Earnings Call Transcript - Seeking Alpha

Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update - wallstreet:online

Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update - ForexTV.com

Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update - StockTitan

Lumos Pharma (LUMO) to Release Earnings on Thursday - Defense World

True Nature (OTCMKTS:TNTY) Stock Passes Below 200 Day Moving Average of $0.29 - Defense World

BNP Paribas Financial Markets Has $307,000 Holdings in Stitch Fix, Inc. (NASDAQ:SFIX) - Defense World

NBT Bancorp Inc. (NASDAQ:NBTB) Shares Acquired by Russell Investments Group Ltd. - Defense World

Janney Montgomery Scott LLC Grows Holdings in FormFactor, Inc. (NASDAQ:FORM) - Defense World

Marinus Pharmaceuticals (NASDAQ:MRNS) Shares Cross Below 200 Day Moving Average of $5.34 - Defense World

Silvaco Group, Inc. (NASDAQ:SVCO) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Proto Labs, Inc. (NYSE:PRLB) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Passes Below 200 Day Moving Average of $2.58 - Defense World

Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 - StockTitan

Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 - ForexTV.com

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Quotes, Forecast and News Summary - Benzinga

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Average Rating of “Buy” by Brokerages - Defense World

Enova International, Inc. (NYSE:ENVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Avino Silver & Gold Mines (NYSE:ASM) Shares Down 7.6% - Defense World

Great-West Lifeco Inc. (TSE:GWO) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

MidWestOne Financial Group (MOFG) Scheduled to Post Earnings on Thursday - Defense World

FirstService (TSE:FSV) Share Price Crosses Above 200-Day Moving Average of $214.46 - Defense World

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Rating of “Buy” from Analysts - Defense World

Lumos Pharma Reports Full Year 2021 Financial Results and Announces Plan to Perform Interim Analyses of OraGrowtH Trials - Barchart

Austin's life sciences sector is booming — can it catch up to other top U.S. hubs? - The Business Journals

Down 16.1% in 4 Weeks, Here's Why Lumos (LUMO) Looks Ripe for a Turnaround - Yahoo New Zealand News

Finanzdaten der Lumos Pharma Inc-Aktie (LUMO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Lumos Pharma Inc-Aktie (LUMO) Insiderhandel

Ähnlich wie LUMO